Clinical Trials Browser

Phase 3 × Pancreatic Neoplasms × Dalteparin × Clear all

NCT00031837 2015-10-14

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Phase 3 Terminated

Gastrointestinal

Pancreatic Neoplasms, Thromboembolism